RCAT

Red Cat Holdings, Inc. Common Stock

$10.18

-4.23%
Jun 23, 2026
Bobby Quantitative Model
Red Cat Holdings is a drone technology company that integrates robotic hardware and software for military, government, and commercial operations, operating within the defense technology and computer hardware industry. The company positions itself as a specialized, agile player in the military drone sector, focusing on small unmanned ISR (Intelligence, Surveillance, Reconnaissance) and precision strike systems like its Arachnid family and Teal drones. The current investor narrative is intensely driven by geopolitical tensions and potential U.S. government investment in domestic drone manufacturers, as highlighted by recent news of a 'Drone Dominance Play' and the company's strategic acquisition of Quaze Technologies to address power bottlenecks, fueling speculation about its ability to capture a share of a massive military budget despite its current lack of profitability.

People also watch

Dell Technologies

Dell Technologies

DELL

Analysis
Arista Networks

Arista Networks

ANET

Analysis
Western Digital

Western Digital

WDC

Analysis
Hewlett Packard Enterprise

Hewlett Packard Enterprise

HPE

Analysis
NetApp

NetApp

NTAP

Analysis

BobbyInvestment Opinion: Should I buy RCAT Today?

Rating & Thesis: RCAT is a speculative Hold. The core thesis is that while the company operates in a compelling thematic niche with improving operations, its extreme valuation and lack of profitability create an asymmetric risk/reward profile that currently favors caution over conviction. The limited analyst coverage, with only one firm providing estimates, offers little anchor for valuation.

Supporting Evidence: The stock trades at a stratospheric 23.26x trailing sales, which is unsustainable for a company with negative earnings and cash flow. While revenue growth of 18.66% YoY is positive, it is not nearly high enough to justify such a multiple without a clear path to profitability. The balance sheet is a clear positive, with a strong current ratio of 15.29 and minimal debt, but this is overshadowed by a TTM free cash flow burn of -$95.78 million. The technical picture shows a stock in recovery (+33.80% over 1 month) but still 39% below its 52-week high, indicating significant volatility and lack of a clear breakout.

Risks & Conditions: The two biggest risks are 1) a failure to achieve profitability leading to dilutive financing, and 2) a compression of its sales multiple if growth decelerates. This Hold rating would upgrade to a Buy if the PS ratio compresses below 10x while revenue growth accelerates above 25% YoY, or if the company announces a major, profitable contract. It would downgrade to a Sell if quarterly cash burn exceeds -$40 million or if revenue growth falls below 10% YoY. Based on current fundamentals, the stock is significantly overvalued relative to its financial performance, trading on narrative rather than numbers.

Sign up to view all

RCAT 12-Month Price Forecast

The assessment is neutral due to a precarious balance between a compelling long-term narrative and untenable short-term valuation. The company's operational trajectory is improving, and its balance sheet provides a runway, but the current price embeds expectations of flawless execution and hyper-growth. The stock is a high-risk, binary bet on contract wins. The stance would upgrade to bullish only upon evidence of accelerating revenue growth (>30% YoY) coupled with a material reduction in cash burn. It would downgrade to bearish if the next quarterly report shows revenue growth deceleration or an acceleration in cash consumption.

Historical Price
Current Price $10.18
Average Target $11
High Target $25
Low Target $5.77

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Red Cat Holdings, Inc. Common Stock's 12-month outlook, with a consensus price target around $13.23 and implied upside of +30.0% versus the current price.

Average Target

$13.23

1 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

1

covering this stock

Price Range

$8 - $13

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Analyst coverage is extremely limited, with only one analyst providing estimates, which signals this is a small-cap stock with minimal institutional research and can lead to higher volatility and less efficient price discovery. The single analyst estimates revenue of $152.09 million and EPS of $0.11, but no consensus price target or recommendation distribution is provided in the data; the institutional ratings show a pattern of reiterated 'Buy' ratings from firms like Needham and Ladenburg Thalmann in early 2026, indicating maintained bullish sentiment among the few covering the name. Without a defined target price range, the strength of the analyst signal is weak, and investors must rely more heavily on their own assessment of the company's execution against its growth narrative and the evolving geopolitical backdrop for drone demand.

Drowning in data?

Find the real signal!

Bulls vs Bears: RCAT Investment Factors

The bull case for RCAT is driven by strong thematic tailwinds, improving operational metrics, and a pristine balance sheet, while the bear case centers on an unsustainable valuation, deep losses, and severe cash burn. Currently, the bear side holds stronger evidence due to the extreme disconnect between its 23x sales multiple and its lack of profitability or positive cash flow. The single most important tension in the investment debate is whether the company's revenue growth can accelerate rapidly enough to justify its current premium valuation before its cash reserves are depleted, or if continued losses will lead to significant dilution and a valuation reckoning.

Bullish

  • Strong Revenue Growth Trajectory: Revenue grew 18.66% YoY to $26.24M in the latest quarter, a significant acceleration from a very small base. This is driven by product sales, which were $37.88M over a longer period, indicating a core hardware business is scaling.
  • Dramatic Gross Margin Improvement: Gross margin improved to +4.24% in Q3 FY2026 from a deeply negative -52.18% in the year-ago quarter. This shows the company is moving toward operational efficiency and better pricing power for its drone products.
  • Robust Balance Sheet with No Debt: The company has a strong current ratio of 15.29 and a minimal debt-to-equity ratio of 0.075. This provides a significant financial cushion to fund operations and strategic acquisitions, such as Quaze Technologies, without the pressure of debt servicing.
  • Powerful Geopolitical & Sector Tailwinds: Recent news highlights a 'Drone Dominance' narrative and potential U.S. government investment in domestic drone makers. The stock's +56.82% 1-year return, vastly outperforming the SPY (+24.99%), reflects this powerful thematic momentum.

Bearish

  • Extreme Valuation with No Profitability: The stock trades at a trailing Price-to-Sales ratio of 23.26x and an EV/Sales of 22.35x. This is an exceptionally high multiple for a company with a -1.77% net margin and negative EPS of -$0.076, implying unrealistic growth expectations.
  • Severe Cash Burn & Dependence on Financing: Free cash flow over the trailing twelve months is -$95.78M, with quarterly operating cash flow at -$36.48M. Despite a $167.87M cash position, this burn rate necessitates future dilutive equity raises or debt, threatening shareholder value.
  • Unproven Business Model at Scale: While revenue is growing, the base is tiny ($26.24M quarterly). The company must prove it can achieve profitability and positive cash flow from operations, which remains years away based on current -$19.66M quarterly net income.
  • High Volatility & Speculative Trading: The stock has a beta of 1.242 and a max drawdown of -60.08% over the past year. Its price is 39% below its 52-week high, indicating high volatility and susceptibility to sharp sentiment shifts, as seen in the recent -13.66% 3-month decline.

RCAT Technical Analysis

The stock is in a volatile but pronounced uptrend over the past year, with a 1-year price change of +56.82%, significantly outperforming the SPY's +24.99%. As of the latest data, the stock closed at $11.44, which positions it approximately 61% above its 52-week low of $5.77 but still 39% below its 52-week high of $18.78, indicating it has room to run but is not at extreme overbought levels. Recent short-term momentum shows a sharp divergence, with a strong +33.80% gain over the past month contrasting with a -13.66% decline over the past three months, suggesting a powerful recovery rally is underway after a significant pullback, potentially driven by recent geopolitical and acquisition news. Key technical levels are clearly defined by the 52-week high of $18.78 as major resistance and the 52-week low of $5.77 as major support; a sustained breakout above $18.78 would signal a resumption of the primary bull trend, while a breakdown below $5.77 would indicate a failure of the long-term thesis. The stock's beta of 1.242 confirms it is approximately 24% more volatile than the broader market, which aligns with its high-risk, high-reward profile and necessitates careful position sizing for risk management.

Beta

1.24

1.24x market volatility

Max Drawdown

-60.1%

Largest decline past year

52-Week Range

$6-$19

Price range past year

Annual Return

+41.8%

Cumulative gain past year

PeriodRCAT ReturnS&P 500
1m+8.2%-1.6%
3m-35.9%+11.7%
6m+12.0%+6.3%
1y+41.8%+22.2%
ytd+11.1%+7.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

RCAT Fundamental Analysis

Revenue is growing but from a very small base, with the most recent quarterly (Q3 FY2026) revenue at $26.24 million, representing a solid 18.66% year-over-year growth; segment data shows Product revenue of $37.88 million and Service revenue of $2.85 million, indicating hardware sales are the primary growth driver. The company is deeply unprofitable, with a net income of -$19.66 million and a gross margin of only 4.24% for the quarter, though this marks a significant improvement from the negative gross margin of -52.18% in the year-ago quarter (Q4 FY2025), showing a trajectory toward operational efficiency. The balance sheet shows a strong current ratio of 15.29 and a very low debt-to-equity ratio of 0.075, indicating excellent short-term liquidity and minimal leverage, but this is offset by severe cash burn, with free cash flow over the trailing twelve months at -$95.78 million and an operating cash flow of -$36.48 million for the latest quarter, meaning the company is heavily dependent on external financing to fund its growth and operations despite its $167.87 million cash position.

Quarterly Revenue

$26235000.0B

2025-12

Revenue YoY Growth

+18.65%

YoY Comparison

Gross Margin

+0.04%

Latest Quarter

Free Cash Flow

$-95780997.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Product
Service

Open an Account, get $2 TSLA now!

Valuation Analysis: Is RCAT Overvalued?

Given the company's negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is an extremely high 23.26x, and the Enterprise Value-to-Sales (EV/Sales) is 22.35x, indicating the market is pricing in tremendous future growth from its current small revenue base. Peer comparison data is not available in the provided dataset, so a sector-level assessment cannot be quantified; however, such a high sales multiple typically implies investors are betting on explosive future revenue expansion and eventual market dominance in a high-growth niche like military drones. Historically, the stock's own PS ratio has fluctuated wildly, from a recent high of 36.10x in Q3 2026 down to 6.38x in Q3 2024; the current 23.26x sits above the middle of this wide range, suggesting the market is optimistic but not at peak euphoria, balancing growth prospects against ongoing losses and cash burn.

PE

-13.2x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -17x~-1x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-11.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: The primary financial risk is the company's severe cash burn, with a TTM free cash flow of -$95.78 million and quarterly operating cash flow of -$36.48 million. Despite a strong cash position of $167.87 million, the current burn rate implies a runway of less than 5 quarters without additional financing, creating high risk of shareholder dilution. Furthermore, while improving, gross margins of 4.24% are razor-thin and leave little room for error, and the company remains deeply unprofitable with a net margin of -1.77%. Revenue, while growing at 18.66% YoY, is from a very small base of $26.24 million per quarter, indicating the business model is unproven at scale.

Market & Competitive Risks: The paramount market risk is valuation compression. Trading at a PS ratio of 23.26x, RCAT is priced for near-perfect execution and hyper-growth. Any deceleration in revenue growth or a shift in market sentiment away from speculative defense tech could cause a severe multiple contraction, as seen in its historical PS range from 6.38x to 36.10x. The stock's beta of 1.242 confirms it is 24% more volatile than the market, amplifying downside moves. Competitively, the company is a small player vying for contracts against larger, established defense primes, and the 'Drone Dominance' thematic driving the stock is highly dependent on continued geopolitical tensions and specific U.S. government budgetary decisions.

Worst-Case Scenario: The worst-case scenario involves a combination of a growth slowdown, continued cash burn, and a sector-wide derating of defense tech multiples. If the company fails to secure major new contracts, revenue growth could stall while losses persist, leading to an urgent need for capital. This could trigger a dilutive equity offering amid negative sentiment, collapsing the stock price. A realistic downside target is a return to its 52-week low of $5.77, which would represent a loss of approximately -50% from the current price of ~$11.44. A re-rating to the lower end of its historical PS range (around 6-8x sales) on stagnant revenue could amplify losses further.

FAQ

The key risks are, in order of severity: 1) Valuation & Funding Risk: The stock's 23x sales multiple is unsustainable if growth slows, and the company burns cash at a rate of -$95.78M annually, risking severe shareholder dilution. 2) Execution Risk: Revenue, while growing at 18.66% YoY, is from a tiny base, and the company must prove it can scale profitably. 3) Competitive & Thematic Risk: The investment thesis is heavily reliant on the 'Drone Dominance' geopolitical narrative and securing large government contracts, which are uncertain and competitive. 4) Volatility Risk: With a beta of 1.242 and a 52-week range from $5.77 to $18.78, the stock is prone to extreme price swings based on sentiment rather than fundamentals.

The 12-month forecast for RCAT is highly bifurcated, with a base case target range of $9.00 to $13.00 (probability 50%), a bull case of $18.78 to $25.00 (probability 25%), and a bear case of $5.77 to $8.00 (probability 25%). The base case, which is most likely, assumes continued steady revenue growth but a contraction in the valuation multiple as cash burn necessitates financing. The bull case depends on a transformative government contract, while the bear case involves growth stalling and a derating. The lack of a broad analyst consensus price target increases forecast uncertainty, making the stock's path highly dependent on specific operational and geopolitical catalysts.

RCAT is significantly overvalued based on conventional fundamental metrics. It trades at a trailing Price-to-Sales ratio of 23.26x and an EV/Sales of 22.35x, which is extremely high for a company with quarterly revenue of only $26.24M and negative net income. Historically, its own PS ratio has ranged from 6.38x to 36.10x, placing the current multiple in the upper half, suggesting the market is optimistic. This valuation implies the market expects explosive future revenue growth and a rapid path to profitability, which is not yet evident in the financials. Compared to profitable defense peers, RCAT trades at a substantial premium for its growth narrative alone.

RCAT is not a good buy for most investors at its current valuation. While the company operates in a high-potential sector and has a strong balance sheet, its extreme Price-to-Sales multiple of 23.26x is disconnected from its lack of profitability and significant cash burn (-$95.78M TTM). The stock is suitable only for speculative investors with a high risk tolerance who are betting on imminent major government contracts. For others, the risk of dilution and multiple compression outweighs the potential upside. The single analyst covering the stock estimates future EPS of $0.11, but this remains a distant projection.

RCAT is unsuitable for short-term trading due to its high volatility (beta 1.242) and reliance on binary news events like contract announcements. It is also a challenging long-term investment because its business model and path to profitability are unproven, and it pays no dividend. The stock is best categorized as a speculative, event-driven holding for investors with a medium-term horizon (2-3 years) who are betting on the company securing major contracts that validate its growth narrative. Given the cash burn, investors should be prepared for potential dilution within the next 12-18 months, which is a key medium-term catalyst or risk.